Sees Q1 adjusted EBTIDA $22M-$24M
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- Cellebrite’s Strategic Positioning and Growth Potential: Buy Rating Affirmed
- Cellebrite announces its Government Cloud platform achieved FedRAMP designation
- Cellebrite price target raised to $28 from $24 at JPMorgan
- CLBT Upcoming Earnings Report: What to Expect?
- Cellebrite announces availability of GenAI capabilities within Guardian